Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4442275
Max Phase: Preclinical
Molecular Formula: C28H28O8
Molecular Weight: 492.52
Molecule Type: Unknown
Associated Items:
ID: ALA4442275
Max Phase: Preclinical
Molecular Formula: C28H28O8
Molecular Weight: 492.52
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)O[C@@H](c1ccccc1)[C@@H](O[C@@H]1[C@@H]2C[C@@H](CC(=O)O2)O[C@H]1c1ccccc1)[C@@H]1CC=CC(=O)O1
Standard InChI: InChI=1S/C28H28O8/c1-17(29)32-25(18-9-4-2-5-10-18)27(21-13-8-14-23(30)34-21)36-28-22-15-20(16-24(31)35-22)33-26(28)19-11-6-3-7-12-19/h2-12,14,20-22,25-28H,13,15-16H2,1H3/t20-,21-,22-,25-,26-,27-,28+/m0/s1
Standard InChI Key: XIBVVAIWCCINAK-WSRKESHLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 492.52 | Molecular Weight (Monoisotopic): 492.1784 | AlogP: 3.76 | #Rotatable Bonds: 7 |
Polar Surface Area: 97.36 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.93 | CX LogD: 3.93 |
Aromatic Rings: 2 | Heavy Atoms: 36 | QED Weighted: 0.43 | Np Likeness Score: 2.03 |
1. Bihud NV, Rasol NE, Imran S, Awang K, Ahmad FB, Mai CW, Leong CO, Cordell GA, Ismail NH.. (2019) Goniolanceolatins A-H, Cytotoxic Bis-styryllactones from Goniothalamus lanceolatus., 82 (9): [PMID:31433181] [10.1021/acs.jnatprod.8b01067] |
Source(1):